comparemela.com

Latest Breaking News On - Berubicin development - Page 1 : comparemela.com

CNS Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Outlook

/PRNewswire/ CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel.

Houston
Texas
United-states
John-climaco
Company-phase
Linkedin
Company-on-twitter
Drug-administration
Nasdaq
Berubicin-development
Exchange-commission
Securities-exchange

CNS Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Outlook

CNS Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Outlook
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Houston
Texas
United-states
John-climaco
Company-phase
Linkedin
Company-on-twitter
Drug-administration
Nasdaq
Berubicin-development
Exchange-commission
Securities-exchange
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.